A new study by an advocacy group for safety-net hospitals say that participants in the 340B drug discount program spend less per patient under Medicare Part B for drugs than hospitals outside of 340B, while still caring for a population of sicker patients.

That was the conclusion of the study by 340B Health, undertaken by healthcare consulting firm Dobson DaVanzo.

Read more.

Want To Stay Up-To-Date On The Latest 340B News?

"*" indicates required fields